Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 12/20 | 0.67 |
| ▸ | MMP2 | P08253 | 11/20 | 0.67 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.53 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.47 |
| ▸ | MMP13 | P45452 | 2/20 | 0.47 |
| ▸ | MMP3 | P08254 | 1/20 | 0.47 |
| ▸ | MMP8 | P22894 | 4/20 | 0.45 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.45 |
| ▸ | PLAU | P00749 | 1/20 | 0.45 |
| ▸ | HPN | P05981 | 1/20 | 0.45 |
| ▸ | MMP12 | P39900 | 3/20 | 0.45 |
| ▸ | MMP14 | P50281 | 3/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2038720 | 1.00 | MMP9 (0.67) | MMP9MMP2ITGB3ITGA2BTDP1 | |
| Hydrochloric Acid SCHEMBL1499337 | 0.99 | MMP9 (0.65) | MMP9MMP2ITGB3ITGA2BTDP1 | |
| Hydrochloric Acid SCHEMBL14059214 | 0.99 | MMP9 (0.65) | MMP9MMP2ITGB3ITGA2BTDP1 | |
| SCHEMBL457772 | 0.93 | MMP9 (0.76) | MMP9MMP2ITGB3ITGA2BTDP1 | |
| SCHEMBL10585071 | 0.93 | MMP9 (0.76) | MMP9MMP2ITGB3ITGA2BTDP1 | |
| SCHEMBL8001084 | 0.93 | MMP9 (0.76) | MMP9MMP2ITGB3ITGA2BTDP1 | |
| SCHEMBL8322406 | 0.92 | MMP9 (0.71) | MMP9MMP2ITGB3ITGA2BTDP1 | |
| Hydrochloric Acid SCHEMBL9087107 | 0.92 | MMP9 (0.74) | MMP9MMP2ITGB3ITGA2BTDP1 | |
| SCHEMBL232590 | 0.91 | MMP9 (0.70) | MMP9MMP2ITGB3ITGA2BTDP1 | |
| SCHEMBL796113 | 0.91 | MMP9 (0.70) | MMP9MMP2ITGB3ITGA2BTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 527 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12458582-B2 | Stabilized hyaluronic acid | CROMA-PHARMA GMBH (AT) | 2025-11-04 | — | — | US | claimed |
| EP-3806918-A1 | STABILIZED HYALURONIC ACID | Croma-Pharma Gesellschaft m.b.H. (AT) | 2021-04-21 | — | — | EP | claimed |
| WO-2019238955-A1 | STABILIZED HYALURONIC ACID | CROMA-PHARMA GMBH (AT) | 2019-12-19 | — | — | WO | claimed |
| US-8257327-B2 | Wound cleansing apparatus with actives | SMITH & NEPHEW PLC (GB) | 2012-09-04 | — | — | US | claimed |
| US-20110263521-A1 | PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF AND USE OF SAME | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2011-10-27 | — | — | US | claimed |
| US-20100323985-A1 | PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF AND USE OF SAME | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2010-12-23 | — | — | US | claimed |
| US-20100298249-A1 | PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF AND USE OF SAME | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2010-11-25 | — | — | US | claimed |
| US-20100249733-A9 | APPARATUS WITH ACTIVES FROM TISSUE | SMITH & NEPHEW PLC (GB) | 2010-09-30 | — | — | US | claimed |
| EP-1562668-B1 | Medical apparatus for irrigating wounds | SMITH & NEPHEW (GB) | 2009-12-02 | — | — | EP | claimed |
| US-7524315-B2 | Apparatus for aspirating, irrigating and cleansing wounds | SMITH & NEPHEW PLC (GB) | 2009-04-28 | — | — | US | claimed |
| US-6635802-B1 | Culturing mammalian cell population in serum starvation media containing apoptosis inhibitor to increase number of cells at G0/G1 stage of cell cycle within cell population, increasing number of nuclear transfer competent cells | THE TEXAS A&M UNIVERSITY SYSTEM | 2003-10-21 | — | — | US | claimed |
| EP-1352627-A2 | Reduction of hair growth | THE GILLETTE COMPANY (US) | 2003-10-15 | — | — | EP | claimed |
| EP-0863741-A2 | REDUCTION OF HAIR GROWTH | HANDELMAN, Joseph H. (US) | 1998-09-16 | — | — | EP | claimed |
| US-5652273-A | APPLYING HEXOKINASE INHIBITOR TO SKIN | GILLETTE COMPANY THE | 1997-07-29 | — | — | US | claimed |
| WO-1997019673-A2 | REDUCTION OF HAIR GROWTH | HANDELMAN, JOSEPH, H. (US) | 1997-06-05 | — | — | WO | claimed |
| US-5532142-A | PROTEINS FOR GENETIC ENGINEERING WITH DNA USING PROTEINASE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1996-07-02 | — | — | US | claimed |
| WO-1995004155-A2 | A METHOD FOR SYNTHESIS OF POLYSACCHARIDES | BROWN MALCOLM R JR (US) | 1995-02-09 | — | — | WO | claimed |
| US-4687666-A | N-PARA-TOSYL-L-LYSINE CHLOROMETHYL KETONE | MINISTERIO DE SANIDAD Y ASISTENCIA SOCIAL INSTITUTO VENEZOLANO DE INVESTIGATIONES CIENTIFICAS (VE) | 1987-08-18 | — | — | US | claimed |
| US-12458582-B2 | Stabilized hyaluronic acid | CROMA-PHARMA GMBH (AT) | 2025-11-04 | — | — | US | disclosed |
| EP-0066786-B1 | METHOD OF PRODUCING A COLON SPECIFIC ANTIGEN P TRYPTIC PEPTIDE AND ANTI-COLON SPECIFIC ANTIGEN P ANTIBODIES | Goldenberg, Milton David (US) | 1986-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12458582-B2 | Stabilized hyaluronic acid | CD44, HSPH1, ACR | MMP9 133/4885MMP2 106/4885ITGB3 868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.